Stereotaxis (STXS) Cash & Current Investments (2010 - 2026)
Stereotaxis (STXS) posted quarterly Cash & Current Investments of $14.6 million for Q1 2026, up 36.74% year-over-year from $10.7 million in Q1 2025, and up 8.9% quarter-over-quarter from $13.4 million in Q4 2025.
Stereotaxis (STXS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Cash & Current Investments for 17 consecutive years, with $14.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 36.74% year-over-year to $14.6 million; the TTM figure through Mar 2026 stood at $14.6 million (up 36.74% YoY), while the FY2025 annual figure was $13.4 million, up 7.92% from the prior year.
- Cash & Current Investments grew to $14.6 million in Q1 2026 per STXS's latest filing, from $13.4 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $49.5 million in Q4 2022 and bottomed at $7.0 million in Q2 2025.
- Historically, Cash & Current Investments has averaged $20.3 million across 5 years, with a median of $15.6 million in 2024.
- Annual changes were most pronounced in 2023 — Cash & Current Investments slumped 80.56% — and 2024, when it surged 157.67%.
- Stereotaxis' Cash & Current Investments stood at $49.5 million in 2022, then tumbled by 57.44% to $21.1 million in 2023, then tumbled by 41.03% to $12.4 million in 2024, then climbed by 7.92% to $13.4 million in 2025, then rose by 8.9% to $14.6 million in 2026.
- Business Quant data shows STXS's Cash & Current Investments at $14.6 million in Q1 2026, $13.4 million in Q4 2025, and $10.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 863.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.68 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 14.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.62 Mn |
| Dec 31, 2025 | 13.42 Mn |
| Sep 30, 2025 | 10.51 Mn |
| Jun 30, 2025 | 6.97 Mn |
| Mar 31, 2025 | 10.69 Mn |
| Dec 31, 2024 | 12.44 Mn |
| Sep 30, 2024 | 11.01 Mn |
| Jun 30, 2024 | 15.65 Mn |
| Mar 31, 2024 | 18.77 Mn |
| Dec 31, 2023 | 21.09 Mn |
| Sep 30, 2023 | 22.63 Mn |
| Jun 30, 2023 | 24.50 Mn |
| Mar 31, 2023 | 7.29 Mn |
| Dec 31, 2022 | 49.54 Mn |
| Sep 30, 2022 | 33.05 Mn |
| Jun 30, 2022 | 35.74 Mn |
| Mar 31, 2022 | 37.47 Mn |
| Dec 31, 2021 | 40.60 Mn |
| Sep 30, 2021 | 41.85 Mn |
| Jun 30, 2021 | 43.54 Mn |